Gallery
Interactive AERO graph showing patient risk and benefit over the cancer research life-cycle of the tyrosine kinase inhibitor, sunitinib. Data taken from a 2015 STREAM publication in JNCI.
Videos
Jonathan Kimmelman’s participation in a discussion hosted by Consilium Scientific “Do We Need Phase 3 Clinical Trials in Oncology”.
Jonathan Kimmelman’s talk “Ethics, Randomized Trials, and Clinical Equipoise” for UAB’s Nutrition Obesity Health Center’s investigator training program.